161 related articles for article (PubMed ID: 7799357)
1. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone.
Denko CW; Boja B; Moskowitz RW
J Rheumatol; 1994 Sep; 21(9):1725-30. PubMed ID: 7799357
[TBL] [Abstract][Full Text] [Related]
2. The role of growth factors in degenerative joint disorders.
Moskowitz RW; Boja B; Denko CW
J Rheumatol Suppl; 1991 Feb; 27():147-8. PubMed ID: 2027117
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
[TBL] [Abstract][Full Text] [Related]
4. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
Denko CW; Malemud CJ
Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
[TBL] [Abstract][Full Text] [Related]
5. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone.
Denko CW; Boja B; Moskowitz RW
J Rheumatol; 1990 Sep; 17(9):1217-21. PubMed ID: 2290165
[TBL] [Abstract][Full Text] [Related]
6. Osteoarthritis, insulin and bone density.
Smythe HA
J Rheumatol; 1987 May; 14 Spec No():91-3. PubMed ID: 3305943
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Malemud CJ
Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
[TBL] [Abstract][Full Text] [Related]
8. [Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters].
Pavelková A; Pavelka K
Vnitr Lek; 2006 May; 52(5):477-80. PubMed ID: 16771094
[TBL] [Abstract][Full Text] [Related]
9. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study.
Vezyroglou G; Mitropoulos A; Antoniadis C
J Rheumatol; 1996 Apr; 23(4):672-6. PubMed ID: 8730125
[TBL] [Abstract][Full Text] [Related]
10. Diffuse idiopathic skeletal hyperostosis in diabetes mellitus, impaired glucose tolerance and obesity.
Coaccioli S; Fatati G; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
Panminerva Med; 2000 Dec; 42(4):247-51. PubMed ID: 11294086
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Boja B; Malemud CJ
Front Biosci; 2002 Apr; 7():a37-43. PubMed ID: 11897552
[TBL] [Abstract][Full Text] [Related]
12. Intra-erythrocyte deposition of growth hormone in rheumatic diseases.
Denko CW; Boja B; Malemud CJ
Rheumatol Int; 2003 Jan; 23(1):11-4. PubMed ID: 12548436
[TBL] [Abstract][Full Text] [Related]
13. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin, IGF-I,IGF-II and growth hormone, and left ventricular mass in noninsulin-dependent mellitus.
Rabkin SW; Dawson KG; Bhaumick B; O'Brein E; Kendler DL
Can J Cardiol; 1996 Mar; 12(3):264-70. PubMed ID: 8624976
[TBL] [Abstract][Full Text] [Related]
15. [Forestier disease and metabolism disorders. A prospective controlled study of 25 cases].
Troillet N; Gerster JC
Rev Rhum Ed Fr; 1993 Apr; 60(4):274-9. PubMed ID: 8167624
[TBL] [Abstract][Full Text] [Related]
16. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
Yuen KC; Bennett RM; Hryciw CA; Cook MB; Rhoads SA; Cook DM
Growth Horm IGF Res; 2007 Feb; 17(1):82-8. PubMed ID: 17289417
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
18. Diffuse idiopathic skeletal hyperostosis: a distinct clinical entity.
Mader R
Isr Med Assoc J; 2003 Jul; 5(7):506-8. PubMed ID: 12901248
[TBL] [Abstract][Full Text] [Related]
19. Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus.
Sahin G; Polat G; Bagis S; Milcan A; Erdogan C
J Womens Health (Larchmt); 2002 Nov; 11(9):801-4. PubMed ID: 12626079
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
